Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides

Applied Radiation and Isotopes

Volumn 69, Issue 2, 2011, Pages 308-315

  de Blois, Erik ^a   Sze Chan, Ho ^a   Naidoo, Clive ^b   Prince, Deidre ^b   Krenning, Eric P ^a   Breeman, Wouter A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Themba LABS   (South Africa)

Author keywords

68Ga; 68Ge 68Ga generator; DOTA peptide; Ion exchange purification; Radiolabelling; Radionuclide purity

Indexed keywords

68GA; 68GE/68GA GENERATOR; DOTA-PEPTIDE; RADIOLABELLING; RADIONUCLIDE PURITY;

ACETONE; CONCENTRATION (PROCESS); DESORPTION; ETHANOL; GERMANIUM; HYDROCHLORIC ACID; ION EXCHANGE; METAL IONS; NUCLEAR MEDICINE; PEPTIDES; POSITIVE IONS; RADIOISOTOPES; SODIUM CHLORIDE;

PURIFICATION;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ALCOHOL; CHLORIDE; ENDOTOXIN; GALLIUM 68; GERMANIUM 68; METAL ION; OCTREOTATE[1 PHENYL 3 TYROSINE]1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PHENYLALANYLTYROSYLOCTREOTATE; RADIOISOTOPE; SODIUM CHLORIDE; TIN OXIDE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GALLIUM; GERMANIUM; PEPTIDE; RADIOPHARMACEUTICAL AGENT; SINGLE HETEROCYCLIC RINGS; TIN DERIVATIVE; TIN DIOXIDE;

ARTICLE; CHEMICAL REACTION; COLUMN CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DESORPTION; FRACTIONATION; ION EXCHANGE; ISOTOPE LABELING; PH; PRIORITY JOURNAL; PURIFICATION; RADIOACTIVITY; RADIOASSAY; SOLID PHASE EXTRACTION; CHEMISTRY; ISOLATION AND PURIFICATION; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; SYNTHESIS;

GALLIUM RADIOISOTOPES; GERMANIUM; HETEROCYCLIC COMPOUNDS, 1-RING; ISOTOPE LABELING; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOPHARMACEUTICALS; SOLID PHASE EXTRACTION; TIN COMPOUNDS;

EID: 78650309698     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2010.11.015     Document Type: Article

References (23)

1. 2O for target, solvent extraction for radiochemical separation and SnO(2)for the preparation of a Ge-68/Ga-68 generator. J. Radioanal. Nucl. Chem. 2006, 268:25-32.
2. 68Ga-labeled radiotracers. Nucl. Med. Biol. 2007, 34:121-127.
3. 68Ga-labelled tracers in clinical routineg. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:978-981.
4. Breeman W.A., de Jong M., Kwekkeboom D.J., Valkema R., Bakker W.H., Kooij P.P., Visser T.J., Krenning E.P. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur. J. Nucl. Med. 2001, 28:1421-1429.
5. 177Lu at high specific activities. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:917-920.
6. 68Ga. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:478-485.
7. Breeman W.A.P., de Blois E., Chan H.S., Krenning E.P. Maintaining radiochemical purity of peptides for receptor-targeting. J. Labelled Compds. Radiopharm. 2009, 52:S270.
8. 68Ga-labelled peptides. Nucl. Med. Commun. 2007, 28:870-875.
9. EU guidelines to good manufacturing practice medicinal products for human and veterinary use, 2005. Part II: basic requirements for active substances used as starting materials. EudraLex-the rules governing medicinal products in the European Union 4.
10. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol. Imaging 2008, 3:67-77.
11. Fritz J.S., Rettig T.A. Separation of metals by cation exchange in acetone-water-hydrochloric-acid. Anal. Chem. 1962, 34:1562-1566.
12. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J. Nucl. Med. 2007, 48:508-518.
13. 68Ga milking and concentration system. Appl. Radiat. Isot. 2010, 68:1057-1059.
14. Jonard P., Jamar F., Walrand S., Labar D., Marttieu I., Smith C., Kvols L., Krenning E.P., Pauwels S. J. Nucl. Med. 2000, 41:260P.
15. Konijnenberg M.W., Breeman W.A.P. Estimates for the biodistribution and dosimetry of 68Ge in 68Ga PET imaging. J. Labelled Compds. Radiopharm. 2009, 52:S116.
16. Loc'h C., Maziere B., Comar D. A new generator for ionic gallium-68. J. Nucl. Med. 1980, 21:171-173.
17. 68Ga generator systems for radiopharmaceutical production. Int. J. Appl. Radiat. Isot. 1984, 35:521-524.
18. 68Ga-labelled DOTA-derivatised peptide ligands. Eur. J. Nucl. Med. Mol. Imaging 2004, 31:1097-1104.
19. Ocak M., Antretter M., Knopp R., Kunkel F., Petrik M., Bergisadi N., Decristoforo C. Full automation of (68)Ga labelling of DOTA-peptides including cation exchange prepurification. Appl. Radiat. Isot. 2009, 68:297-302.
20. Strelow F., Victor A., Zyl C.v., Eloff C. Distribution coefficients and cation exchange behavior of elements in hydrochloric acid-acetone. Anal. Chem. 1971, 43:870-876.
21. Velikyan I., Beyer G.J., Langstrom B. Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity. Bioconjug. Chem. 2004, 15:554-560.
22. Velikyan I., Sundin A., Eriksson B., Lundqvist H., Sorensen J., Bergstrom M., Langstrom B. In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass. Nucl. Med. Biol 2010, 37:265-275.
23. Zhernosekov K.P., Filosofov D.V., Baum R.P., Aschoff P., Bihl H., Razbash A.A., Jahn M., Jennewein M., Rosch F. Processing of generator-produced 68Ga for medical application. J. Nucl. Med. 2007, 48:1741-1748.